Analytics India Magazine ·
Trump Tariff to Push Indian Pharma Co to Embrace AI, Cost-Efficient R&D
The proposed 10% tariff, which mirrors India’s tax on US drug imports, could severely impact profit margins for generic drug producers.
Read full article on AIM